Prostate Cancer Reports


Volume 1 Number 5
 May 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Number 5, May 2013

CONTENTS


Clinical & Lab investigations
Localized prostate cancer
Locally advanced prostate cancer
Intermediate-risk PCa
Active surveillance
Recurrent prostate cancer


CLINICAL & LAB INVESTIGATIONS


Cholesterol

Kirby M.
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
BJU Int. 2013 May;111(6):854-6. doi: 10.1111/j.1464-410X.2012.11722.x.
Abstract | Related citations


Functional outcomes

Ellison JS, He C, Wood DP.
Early Post-Operative Urinary and Sexual Function Predicts Functional Recovery at One Year Following Prostatectomy.
J Urol. 2013 Apr 19. doi:pii: S0022-5347(13)04095-0. 10.1016/j.juro.2013.04.045. [Epub ahead of print]
Abstract | Related citations


Jakobsson L, Persson L, Lundqvist P.
Daily life and life quality 3 years following prostate cancer treatment.
BMC Nurs. 2013 Apr 10;12:11. doi: 10.1186/1472-6955-12-11.
Abstract | Full text | Related citations


Gleason scoring system

Rapiti E, Schaffar R, Iselin C, Miralbell R, Pelte MF, Weber D, Zanetti R, Neyroud-Caspar I, Bouchardy C
Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study.
BMC Urol. 2013 Apr 11;13:19. doi: 10.1186/1471-2490-13-19.
Abstract | Full text | Related citations


Inflammation

Klink JC, Bañez LL, Gerber L, Lark A, Vollmer RT, Freedland SJ.
Intratumoral inflammation is associated with more aggressive prostate cancer.
World J Urol. 2013 Apr 2. [Epub ahead of print]
Abstract | Related citations


Integrative medicine

Bassett JK, Severi G, Hodge AM, Macinnis RJ, Gibson RA, Hopper JL, English DR, Giles GG.
Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
Int J Cancer. 2013 Apr 11. doi: 10.1002/ijc.28203. [Epub ahead of print]
Abstract | Related citations


Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.
Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer.
PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.
Abstract | Full text | Related citations


Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR.
Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
Int J Oncol. 2013 Jul;43(1):194-200. doi: 10.3892/ijo.2013.1920. Epub 2013 Apr 24.
Abstract | Related citations


Kroeger N, Belldegrun AS, Pantuck AJ.
Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.
Evid Based Complement Alternat Med. 2013;2013:701434. doi: 10.1155/2013/701434. Epub 2013 Mar 26.
Abstract | Full text | Related citations


Meng H, Hu W, Chen Z, Shen Y.
Fruit and vegetable intake and prostate cancer risk: A meta-analysis.
Asia Pac J Clin Oncol. 2013 Apr 1. doi: 10.1111/ajco.12067. [Epub ahead of print]
Abstract | Related citations


Nicastro HL, Dunn BK.
Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).
Nutrients. 2013 Apr 3;5(4):1122-48. doi: 10.3390/nu5041122.
Abstract | Full text | Related citations


Pelser C, Mondul AM, Hollenbeck AR, Park Y.
Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study.
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707. doi: 10.1158/1055-9965.EPI-12-1196-T.
Abstract | Related citations


Sorongon-Legaspi MK, Chua M, Sio MC, Morales M Jr.
Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer.
Prostate Cancer. 2013;2013:875615. doi: 10.1155/2013/875615. Epub 2013 Mar 25.
Abstract | Full text | Related citations



Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.
Consumption of Fish Products across the Lifespan and Prostate Cancer Risk.
PLoS One. 2013 Apr 17;8(4):e59799. doi: 10.1371/journal.pone.0059799. Print 2013.
Abstract | Full text | Comment in | Related citations


Lymphadenectomy

Gonzalez-Roibon N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ.
Comparison of Biochemical RecurrenceFree Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer.
Int J Surg Pathol. 2013 Apr 5. [Epub ahead of print]
Abstract | Related citations


Overview

Gomez-Veiga F, Pertega Diaz S, Martinez Breijo S.
Prostate cancer: Treat or not treat?
Actas Urol Esp. 2013 Apr 25. doi:pii: S0210-4806(13)00056-9. 10.1016/j.acuro.2013.02.001. [Epub ahead of print] Spanish.
Abstract | Full text | Related citations


Prostate-specific antigen

Hernández C, Morote J, Miñana B, Cózar JM.
The Role of Prostate-Specific Antigen in Light of New Scientific Evidence.
Actas Urol Esp. 2013 Apr 19. doi:pii: S0210-4806(13)00036-3. 10.1016/j.acuro.2013.01.009. [Epub ahead of print] Spanish.
Abstract | Full text | Related citations


Mehta NH, Kamrava M, Wang PC, Steinberg M, Demanes J.
Prostate-Specific Antigen Bounce After High-Dose-Rate Monotherapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2013 Apr 11. doi:pii: S0360-3016(13)00256-3. 10.1016/j.ijrobp.2013.02.032. [Epub ahead of print]
Abstract | Related citations


Risk and mortality



Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF.
Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer.
J Natl Cancer Inst. 2013 May 15;105(10):711-8. doi: 10.1093/jnci/djt059. Epub 2013 Apr 24.
Abstract | Full text | Related citations


Madan RA, Shah AA, Dahut WL.
Is it time to reevaluate definitive therapy in prostate cancer?
J Natl Cancer Inst. 2013 May 15;105(10):683-5. doi: 10.1093/jnci/djt094. Epub 2013 Apr 24
Abstract | Related citations


Roobol MJ, Carlsson SV.
Risk stratification in prostate cancer screening.
Nat Rev Urol. 2013 May;10(5):248. doi: 10.1038/nrurol.2013.84. Epub 2013 Apr 23.
Abstract | Full text | Related citations


Shi Z, Pinnock CB, Kinsey-Trotman S, Borg M, Moretti KL, Walsh S, Kopsaftis T.
Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death.
Radiother Oncol. 2013 Apr 23. doi:pii: S0167-8140(13)00161-8. 10.1016/j.radonc.2013.03.030. [Epub ahead of print]
Abstract | Related citations


Tyson MD, Andrews PE, Etzioni DA, Ferrigni RG, Humphreys MR, Swanson SK, Castle EK.
Marital status and prostate cancer outcomes.
Can J Urol. 2013 Apr;20(2):6702-6.
Abstract | Related citations


Robotic prostatectomy

Huang KH, Carter SC, Hu JC.
Does Robotic Prostatectomy Meet Its Promise in the Management of Prostate Cancer?
Curr Urol Rep. 2013 Apr 7. [Epub ahead of print]
Abstract | Related citations

LOCALIZED PROSTATE CANCER


Ehdaie B, Eastham JA.
Effective Management of Localized Prostate Cancer: First, Do No Harm.
Eur Urol. 2013 Mar 26. doi:pii: S0302-2838(13)00259-5. 10.1016/j.eururo.2013.03.035. [Epub ahead of print]
Abstract | Full text | Related citations


Kollmeier MA, Fidaleo A, Pei X, Cohen G, Zaider M, Mo Q, Cox B, Yamada Y, Zelefsky MJ.
Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
BJU Int. 2013 Apr 3. doi: 10.1111/j.1464-410X.2012.11663.x. [Epub ahead of print]
Abstract | Related citations


Silberstein JL, Eastham JA.
Re: radical prostatectomy versus observation for localized prostate cancer.
Eur Urol. 2013 Jun;63(6):1130-1. doi: 10.1016/j.eururo.2013.03.020.
Abstract | Full text | Related citations


van Tol-Geerdink JJ, Leer JW, van Oort IM, van Lin EJ, Weijerman PC, Vergunst H, Witjes JA, Stalmeier PF.
Quality of life after prostate cancer treatments in patients comparable at baseline.
Br J Cancer. 2013 Mar 14;108(9):1784-9. doi: 10.1038/bjc.2013.181. Epub 2013 Apr 23.
Abstract | Related citations

LOCALLY ADVANCED PROSTATE CANCER


Duthie JB, Murphy DG.
Re: Postoperative Radiotherapy After Radical Prostatectomy for High-risk Prostate Cancer: Long-term Results of a Randomised Controlled Trial (EORTC Trial 22911).
Eur Urol. 2013 Jun;63(6):1131-2. doi: 10.1016/j.eururo.2013.03.021.
Abstract | Full text | Related citations

INTERMEDIATE-RISK PROSTATE CANCER


Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA.
Critical evaluation of MRI-targeted TRUS-guided transperineal fusion biopsy for detection of prostate cancer.
J Urol. 2013 Apr 19. doi:pii: S0022-5347(13)04093-7. 10.1016/j.juro.2013.04.043. [Epub ahead of print]
Abstract | Related citations


Patel N, Faria S, Cury F, David M, Duclos M, Shenouda G, Ruo R, Souhami L.
Hypofractionated Radiation Therapy (66 Gy in 22 Fractions at 3 Gy per Fraction) for Favorable-Risk Prostate Cancer: Long-term Outcomes.
Int J Radiat Oncol Biol Phys. 2013 Apr 15. doi:pii: S0360-3016(13)00171-5. 10.1016/j.ijrobp.2013.02.010. [Epub ahead of print]
Abstract | Related citations

ACTIVE SURVEILLANCE


Al Edwan G, Fleshner N.
5-Alpha Reductase Inhibitors in Patients on Active Surveillance: Do the Benefits Outweigh the Risk?
Curr Urol Rep. 2013 Apr 12. [Epub ahead of print]
Abstract | Related citations


Iremashvili V, Burdick-Will J, Soloway MS.
Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression.
BJU Int. 2013 Apr 2. doi: 10.1111/bju.12112. [Epub ahead of print]
Abstract | Related citations


Klotz L.
Active surveillance: patient selection.
Curr Opin Urol. 2013 May;23(3):239-44. doi: 10.1097/MOU.0b013e32835f8f6b.
Abstract | Related citations

RECURRENT PROSTATE CANCER


Bjerklund Johansen TE, Witzsch U, Greene D.
Salvage treatment in prostate cancer: a clinical approach.
Expert Rev Anticancer Ther. 2013 May;13(5):613-23. doi: 10.1586/era.13.35.
Abstract | Related citations


Dariane C, Le Cossec C, Drouin SJ, Wolff B, Granger B, Mozer P, Bitker MO, Shariat SF, Cussenot O, Rouprêt M.
Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL.
World J Urol. 2013 Apr 26. [Epub ahead of print]
Abstract | Related citations


Glass JM.
Prostate cancer families - predicting disease before and after the radical.
BJU Int. 2013 Apr;111(4):527-8. doi: 10.1111/j.1464-410X.2013.10817.x.
Abstract | Full text | Related citations



Johnson S, Jackson W, Li D, Song Y, Foster C, Foster B, Zhou J, Vainshtein J, Feng F, Hamstra D.
The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific Mortality, and Overall Mortality After Salvage Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2013 Apr 2. doi:pii: S0360-3016(13)00184-3. 10.1016/j.ijrobp.2013.02.016. [Epub ahead of print]
Abstract | Related citations


Kaplan JR, Kowalczyk KJ, Borza T, Gu X, Lipsitz SR, Nguyen PL, Friedlander DF, Trinh QD, Hu JC.
Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy.
BJU Int. 2013 Apr 2. doi: 10.1111/bju.12079. [Epub ahead of print]
Abstract | Related citations


Kristiansen A, Wiklund F, Wiklund P, Egevad L.
Prognostic significance of patterns of seminal vesicle invasion in prostate cancer.
Histopathology. 2013 Jun;62(7):1049-56. doi: 10.1111/his.12104. Epub 2013 Apr 9.
Abstract | Related citations


Nakayama H, Kanemoto A, Kikuchi K, Matsuki K, Tomobe M, Tsukamoto S, Takeshima H, Oshiro Y, Sugahara S, Tokuuye K.
Delayed radiotherapy for patients with localized prostate cancer: validation by propensity score matching.
Anticancer Res. 2013 Apr;33(4):1629-33.
Abstract | Related citations


Papachristofilou A, Zimmermann F.
Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.
BJU Int. 2013 Apr;111(4):E142-3. doi: 10.1111/j.1464-410X.2013.11397_9.x.
Abstract | Full text | Related citations


Ruppender NS, Morrissey C, Lange PH, Vessella RL.
Dormancy in solid tumors: implications for prostate cancer.
Cancer Metastasis Rev. 2013 Apr 24. [Epub ahead of print]
Abstract | Related citations


Schiavina R, Ceci F, Borghesi M, Brunocilla E, Vagnoni V, Gacci M, Castellucci P, Nanni C, Martorana G, Fanti S.
The Dilemma of Localizing Disease Relapse After Radical Treatment for Prostate Cancer: Which is The Value of The Actual Imaging Techniques?
Curr Radiopharm. 2013 Apr 16. [Epub ahead of print]
Abstract | Related citations